HIV Citation List: January 21, 2011- February 3, 2011

Pubmed citations:

1. 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: Influence of the alkylation of position 4. Billamboz, M., F. Bailly, C. Lion, C. Calmels, M.L. Andreola, M. Witvrouw, F. Christ, Z. Debyser, L. De Luca, A. Chimirri, and P. Cotelle. European Journal of Medicinal Chemistry, 2011. 46(2): p. 535-546; PMID[21185110].

[Pubmed], HIV_0121-020411.

2. Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5. Bodiwala, H.S., S. Sabde, P. Gupta, R. Mukherjee, R. Kumar, P. Garg, K.K. Bhutani, D. Mitra, and I.P. Singh. Bioorganic and Medicinal Chemistry, 2011. 19(3): p. 1256-1263; PMID[21227704].

[Pubmed], HIV_0121-020411.

3. HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation. De Luca, L., S. De Grazia, S. Ferro, R. Gitto, F. Christ, Z. Debyser, and A. Chimirri. European Journal of Medicinal Chemistry, 2011. 46(2): p. 756-764; PMID[21227550].

[Pubmed], HIV_0121-020411.

4. Novel HIV-1 protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran, that are potent against multi-PI-resistant HIV-1 variants. Ide, K., M. Aoki, M. Amano, Y. Koh, R.S. Yedidi, D. Das, S. Leschenko, B. Chapsal, A.K. Ghosh, and H. Mitsuya. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]. PMID[21282450].

[Pubmed], HIV_0121-020411.

5. In Vitro Antiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor. Kobayashi, M., T. Yoshinaga, T. Seki, C. Wakasa-Morimoto, K.W. Brown, R. Ferris, S.A. Foster, R.J. Hazen, S. Miki, A. Suyama-Kagitani, S. Kawauchi-Miki, T. Taishi, T. Kawasuji, B.A. Johns, M.R. Underwood, E.P. Garvey, A. Sato, and T. Fujiwara. Antimicrobial Agents and Chemotherapy, 2011. 55(2): p. 813-821; PMID[21115794].

[Pubmed], HIV_0121-020411.

6. Mirabamides E-H, HIV-Inhibitory Depsipeptides from the Sponge Stelletta clavosa. Lu, Z., R.M. Van Wagoner, M.K. Harper, H.L. Baker, J.N. Hooper, C.A. Bewley, and C.M. Ireland. Journal of Natural Products, 2011. [Epub ahead of print]. PMID[21280591].

[Pubmed], HIV_0121-020411.

7. The impact of the N348I mutation in HIV-1 reverse transcriptase, on non-nucleoside reverse transcriptase inhibitor resistance in non subtype B HIV-1. McCormick, A.L., C.M. Parry, A. Crombe, R.L. Goodall, R.K. Gupta, P. Kaleebu, C. Kityo, M. Chirara, G.J. Towers, and D. Pillay. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]. PMID[21282419].

[Pubmed], HIV_0121-020411.

8. Rational Approaches for the Design of Effective Human Immunodeficiency Virus Type 1 Nonnucleoside Reverse Transcriptase Inhibitors. Ribone, S.R., M.A. Quevedo, M. Madrid, and M.C. Brinon. Journal of Chemical Information and Modeling, 2011. 51(1): p. 130-138; PMID[21133347].

[Pubmed], HIV_0121-020411.

9. Human Immunodeficiency Virus Type 1 (Cross-) Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors Currently Under Development as Microbiocides. Selhorst, P., A.C. Vazquez, K. Terrazas-Aranda, J. Michiels, K. Vereecken, L. Heyndrickx, J. Weber, M.E. Quinones-Mateu, K.K. Arien, and G. Vanham. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]. PMID[21282453].

[Pubmed], HIV_0121-020411.

10. Single Nucleotide Changes in the HIV RRE Mediate Resistance to Compounds That Inhibit Rev Function. Shuck-Lee, D., H. Chang, E.A. Sloan, M.L. Hammarskjold, and D. Rekosh. Journal of Virology, 2011. [Epub ahead of print]. PMID[21289114].

[Pubmed], HIV_0121-020411.

11. Simple and rapid determination of the enzyme kinetics of HIV-1 reverse transcriptase and anti-HIV-1 agents by a fluorescence based method. Silprasit, K., R. Thammaporn, S. Tecchasakul, S. Hannongbua, and K. Choowongkomon. Journal of Virology Methods, 2011. 171(2): p. 381-387; PMID[21167206].

[Pubmed], HIV_0121-020411.

12. Compounds from Kadsura angustifolia with anti-HIV activity. Sun, R., H.C. Song, C.R. Wang, K.Z. Shen, Y.B. Xu, Y.X. Gao, Y.G. Chen, and J.Y. Dong. Bioorganic & Medicinal Chemistry Letters, 2011. 21(3): p. 961-965; PMID[21232955].

[Pubmed], HIV_0121-020411.

13. Synthesis, QSAR and anti-HIV activity of new 5-benzylthio-1,3,4-oxadiazoles derived from alpha-amino acids. Syed, T., T. Akhtar, N.A. Al-Masoudi, P.G. Jones, and S. Hameed. Journal of Enzyme Inhibition and Medicinal Chemistry, 2011. [Epub ahead of print]. PMID[21250823].

[Pubmed], HIV_0121-020411.

14. Structure-activity relationship studies of 1-(4-chloro-2,5-dimethoxyphenyl)-3-(3-propoxypropyl)thiourea, a non-nucleoside reverse transcriptase inhibitor of human immunodeficiency virus type-1. Weitman, M., K. Lerman, A. Nudelman, D.T. Major, A. Hizi, and A. Herschhorn. European Journal of Medicinal Chemistry, 2011. 46(2): p. 447-467; PMID[21159409].

[Pubmed], HIV_0121-020411.

15. A novel retinoic acid, catechin hydrate and mustard oil-based emulsion for enhanced cytokine and antibody responses against multiple strains of HIV-1 following mucosal and systemic vaccinations. Yu, M. and M. Vajdy. Vaccine, 2011. [Epub ahead of print]. PMID[21272602].

[Pubmed], HIV_0121-020411.

16. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 Inhibition. Zhou, J., Y. Shu, P. Guo, D.D. Smith, and J.J. Rossi. Methods, 2011. [EPUB AHEAD OF PRINT]. PMID[21256218].

[Pubmed], HIV_0121-020411.

17. In Vivo Patterns of Resistance to the HIV Attachment Inhibitor BMS-488043. Zhou, N., B. Nowicka-Sans, S. Zhang, L. Fan, J. Fang, H. Fang, Y.F. Gong, B. Eggers, D.R. Langley, T. Wang, J. Kadow, D. Grasela, G.J. Hanna, L. Alexander, R. Colonno, M. Krystal, and P.F. Lin. Antimicrobial Agents and Chemotherapy, 2011. 55(2): p. 729-737; PMID[21078948].

[Pubmed], HIV_0121-020411.

ISI Web of Knowledge citations:

18. Efficient and Practical One-Pot Conversions of N-Tosyltetrahydroisoquinolines into Isoquinolines and of N-Tosyltetrahydro-beta-carbolines into beta-Carbolines through Tandem beta-Elimination and Aromatization. Dong, J., X.X. Shi, J.J. Yan, J. Xing, Q.A. Zhang, and S. Xiao. European Journal of Organic Chemistry, 2010(36): p. 6987-6992; ISI[000285311000015].

[WOS], HIV_0121-020411.

19. Rapid synthesis of 2 ',3 '-dideoxy-3 'beta-fluoro-pyrimidine nucleosides from 2 '-deoxypyrimidine nucleosides. Khalil, A., C. Mathe, and C. Perigaud. Bioorganic Chemistry, 2010. 38(4-6): p. 271-274; ISI[000285403000022].

[WOS], HIV_0121-020411.

20. Grifonin-1: A Small HIV-1 Entry Inhibitor Derived from the Algal Lectin, Griffithsin. Micewicz, E.D., A.L. Cole, C.L. Jung, H. Luong, M.L. Phillips, P. Pratikhya, S. Sharma, A.J. Waring, A.M. Cole, and P. Ruchala. PLoS ONE, 2010. 5(12): e14360; ISI[000285381200010].

[WOS], HIV_0121-020411.

21. Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replication. Skerlj, R., G. Bridger, E. McEachern, C. Harwig, C. Smith, T. Wilson, D. Veale, H. Yee, J. Crawford, K. Skupinska, R. Wauthy, W. Yang, Y.B. Zhu, D. Bogucki, M. Di Fluri, J. Langille, D. Huskens, E. De Clercq, and D. Schols. Bioorganic & Medicinal Chemistry Letters, 2011. 21(1): p. 262-266; ISI[000285544400051].

[WOS], HIV_0121-020411.